Outcomes of stereotactic body radiotherapy 60 Gy in 8 fractions when prioritizing organs at risk for central and ultracentral lung tumors

被引:0
|
作者
Yizhou Zhao
Eman Khawandanh
Steven Thomas
Susan Zhang
Emma M. Dunne
Mitchell Liu
Devin Schellenberg
机构
[1] Department of Radiation Oncology,
[2] BC Cancer Surrey,undefined
[3] Present Address: Department of Radiation Oncology,undefined
[4] CHU de Québec,undefined
[5] Department of Medical Physics,undefined
[6] BC Cancer Vancouver,undefined
[7] Department of Radiation Oncology,undefined
[8] BC Cancer Vancouver,undefined
来源
关键词
Stereotactic body radiotherapy; Central; Ultracentral; Lung tumors; 60 Gy in 8 fractions;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [1] Outcomes of Stereotactic Body Radiotherapy 60 Gy in 8 Fractions when Prioritizing Organs at Risk for Central and Ultracentral Lung Tumors
    Zhao, Yizhou
    Khawandanh, Eman
    Zhang, Susan
    Dunne, Emma
    Schellenberg, Devin
    Liu, Mitchell
    Huang, Vicky
    Hyde, Derek
    Teke, Tony
    Thomas, Steven
    [J]. MEDICAL PHYSICS, 2019, 46 (11) : 5386 - 5386
  • [2] Outcomes of stereotactic body radiotherapy 60 Gy in 8 fractions when prioritizing organs at risk for central and ultracentral lung tumors
    Zhao, Yizhou
    Khawandanh, Eman
    Thomas, Steven
    Zhang, Susan
    Dunne, Emma M.
    Liu, Mitchell
    Schellenberg, Devin
    [J]. RADIATION ONCOLOGY, 2020, 15 (01)
  • [3] Safety analysis of Stereotactic Body Radiotherapy 8 fractions of 7,5 Gy for Ultracentral Lung Tumors
    Baena, E.
    Manes, A.
    Villalobos, M.
    Gutierrez, B.
    Arellano, A.
    Moreno, S.
    Luguera, E.
    Molero, J.
    Melero, A.
    Villa, S.
    Jove, J.
    [J]. RADIOTHERAPY AND ONCOLOGY, 2021, 161 : S988 - S989
  • [4] Safety of Stereotactic Body Radiotherapy for Central, Ultracentral, and Paramediastinal Lung Tumors
    Daly, Megan
    Novak, Jennifer
    Monjazeb, Arta
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S1066 - S1066
  • [5] The safety and effectiveness of stereotactic body radiotherapy for central versus ultracentral lung tumors
    Chang, Joe H.
    Poon, Ian
    Erler, Darby
    Zhang, Liying
    Cheung, Patrick
    [J]. RADIOTHERAPY AND ONCOLOGY, 2018, 129 (02) : 277 - 283
  • [6] Stereotactic body radiotherapy (SBRT) for central and ultracentral node-negative lung tumors
    Owen, Dawn
    Sio, Terence T.
    [J]. JOURNAL OF THORACIC DISEASE, 2020, 12 (11) : 7024 - 7031
  • [7] Stereotactic ablative radiotherapy of 60 Gy in eight fractions is safe for ultracentral non-small cell lung cancer
    Yang, Dan
    Cui, Jianing
    Zhao, Jun
    You, Jing
    Yu, Rong
    Yu, Huiming
    Jiang, Leilei
    Li, Dongming
    Xu, Bo
    Shi, Anhui
    [J]. THORACIC CANCER, 2020, 11 (03) : 754 - 761
  • [8] Oncological Results and Toxicities of Stereotactic Body Radiotherapy in Ultracentral Lung Tumors
    Yakar, Melek
    Etiz, Durmus
    [J]. UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI, 2024, 34 (02): : 84 - 92
  • [9] Progression of Pulmonary Function and Correlation with Survival Following Stereotactic Body Radiotherapy of Central and Ultracentral Lung Tumors
    Regnery, Sebastian
    Eichkorn, Tanja
    Weykamp, Fabian
    Held, Thomas
    Dinges, Lisa-Antonia
    Schunn, Fabian
    Winter, Hauke
    Thomas, Michael
    Debus, Jurgen
    El Shafie, Rami A.
    Adeberg, Sebastian
    Hoerner-Rieber, Juliane
    [J]. CANCERS, 2020, 12 (10) : 1 - 14
  • [10] Late toxicity following stereotactic radiotherapy (SABR) for central and ultracentral lung tumors
    Tekatli, H.
    Lagerwaard, F.
    van Eekelen, R.
    Senan, S.
    [J]. RADIOTHERAPY AND ONCOLOGY, 2023, 182 : S493 - S494